Table 2 Antimicrobial resistance rates among A. baumannii (% resistant)
Antimicrobial | Hospitalized patients n = 7 | Environment n = 13 | Total N = 20 |
|---|---|---|---|
Beta-lactam agents | |||
 Aztreonam | 3 (43%) | 5 (34%) | 8 (40%) |
 Cefepime | 1 (14%) | 0 | 1 (5%) |
 Ceftazidime | 5 (71%) | 1 (8%) | 6 (30%) |
 Imipenem | 1 (14%) | 6 (86%) | 7 (35%) |
 Meropenem | 1 (14%) | 0 | 1 (5%) |
 Piperacillin/tazobactam | 3 (43%) | 11 (85%) | 14 (70%) |
Aminoglycosides | |||
 Amikacin | 3 (43%) | 0 | 3 (15%) |
 Gentamicin | 5 (71%) | 2 (15%) | 7 (35%) |
Quinolones | |||
 Ciprofloxacin | 6 (86%) | 2 (15%) | 8 (40%) |
Others | |||
 Trimethoprim/sulfamethoxazole (SXT) | 4 (57%) | 8 (62%) | 12 (60%) |